In our work, IL-32 in ESCC-derived EV promoted the activation of FAK and STAT3 in macrophages, and the phosphorylation of STAT3 reduced when FAK inhibitor was used in macrophage. This evidence concerns the gene IL32 and esophageal squamous cell carcinoma.